Aspen Neuroscience Moving Forward ~ Stem Cell Clinical Trial News

[redhawk1]

From X - Recent post from Simon Stott, The Science of Parkinson’s:

Busy day for cell therapies:

Aspen Neuroscience @AspenNeuro announces completion of dosing in the 1st & 2nd cohorts in their "ASPIRO" Phase 1/2a trial of their autologous-derived cell therapy (ANPD001) for #Parkinsons

aspenneuroscience.com/aspen-neurosci…

[garygjs]

Thanks, redhawk

And the arguably more exciting news from today:

bayer.com/media/en-us/bluer...

Best of luck, everyone.

[gomelgo in reply to garygjs]

Interesting...when I go to the site, I get this message: "Disclaimer

This website is intended to provide information to an international audience outside the UK. Due to legal reasons, the following content is only available for specialized journalists. To access these pages, please confirm that you are a medical journalist and that you would like to accredit to the Bayer press portal.

I hereby confirm that I am a medical journalist outside the UK."

[gomelgo]

the link is not live for me, can't click on it.